Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	247.6	232.94	172.81	238.71	176.44
Cash & Short-Term Investments	247.6	232.94	172.81	238.71	176.44
Cash Growth	6.29%	34.80%	-27.61%	35.29%	-4.68%
Accounts Receivable	1,744	1,560	1,310	1,286	1,260
Other Receivables	46.62	53.43	36.54	20.28	10.99
Receivables	1,790	1,613	1,346	1,306	1,271
Inventory	315.08	247.33	189.03	186.79	255.64
Prepaid Expenses	7.57	11.35	9.56	10.25	4.68
Other Current Assets	1.94	1.86	0.76	-	-
Total Current Assets	2,362	2,106	1,719	1,742	1,708
Property, Plant & Equipment	297.54	321.4	306.62	224.77	191.24
Long-Term Investments	13.61	16.2	42.31	23.4	0.5
Goodwill	156.2	162.69	206.96	161.06	144.91
Other Intangible Assets	159.25	138.43	121.92	97.4	75.78
Long-Term Accounts Receivable	26.11	29.62	32.15	33.94	34.93
Long-Term Deferred Tax Assets	3.74	4.82	1.78	0.77	1.04
Other Long-Term Assets	18.15	9	6.29	5.04	30.2
Total Assets	3,037	2,789	2,437	2,289	2,187
Accounts Payable	2,357	2,079	1,662	1,616	1,663
Accrued Expenses	64.5	56.53	49.43	43.48	32.97
Current Portion of Long-Term Debt	-	0.91	1.15	0.39	0.06
Current Portion of Leases	21.31	26.6	22.06	20.14	16.2
Current Income Taxes Payable	6.03	6.55	6.52	4.59	2.61
Other Current Liabilities	11.32	15.65	13.42	4.3	18.39
Total Current Liabilities	2,460	2,185	1,754	1,689	1,734
Long-Term Debt	-	0.07	0.97	0.92	0.43
Long-Term Leases	177.16	187.59	188.6	145.37	137.54
Long-Term Deferred Tax Liabilities	12.94	16.41	19.71	17.63	16.22
Other Long-Term Liabilities	3.52	1.69	6.46	1.42	0.5
Total Liabilities	2,655	2,392	1,972	1,858	1,891
Common Stock	5.11	5.11	5.09	5.07	4.64
Additional Paid-In Capital	347.19	345.07	340.97	339.73	218.91
Retained Earnings	32.21	32.67	91.58	75.97	65.65
Comprehensive Income & Other	-16.13	-11.77	-1.93	3.61	5.49
Total Common Equity	368.38	371.08	435.7	424.37	294.69
Minority Interest	13.77	25.04	28.78	5.86	0.98
Shareholders' Equity	382.14	396.12	464.48	430.23	295.67
Total Liabilities & Equity	3,037	2,789	2,437	2,289	2,187
Total Debt	198.47	215.18	212.77	166.81	154.24
Net Cash (Debt)	49.13	17.76	-39.97	71.9	22.2
Net Cash Growth	176.64%	-	-	223.81%	-18.03%
Net Cash Per Share	0.10	0.03	-0.08	0.14	0.05
Filing Date Shares Outstanding	510.75	510.72	508.7	506.57	463.49
Total Common Shares Outstanding	510.75	510.72	508.7	506.57	463.49
Working Capital	-97.42	-78.39	-35.81	52.94	-25.64
Book Value Per Share	0.72	0.73	0.86	0.84	0.64
Tangible Book Value	52.93	69.97	106.82	165.91	74
Tangible Book Value Per Share	0.10	0.14	0.21	0.33	0.16
Machinery	145.73	148.01	131.88	155.63	133.06
Leasehold Improvements	134.68	131.41	113.03	74.47	71

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.